Trial · NCT02327663
Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
NCT02327663, Phase 4, Unknown, Asian-Pacific Alliance of Liver Disease, Beijing
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Emtricitabine for Naive Chinese Chronic Hepatitis B Patients. Trials, record NCT02327663. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02327663
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
- NCT number
- NCT02327663
- Status
- Unknown
- Phases
- Phase 4
- Enrollment
- 2,000 participants, estimated
- Lead sponsor
- Asian-Pacific Alliance of Liver Disease, Beijing
- Conditions
- Hepatitis B, Chronic
- Interventions
- Emtricitabine
- First posted
- 2014-12-30
- Last updated
- 2014-12-30
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | virological response rate | week 96 | HBV DNA \< 500 copies/ml |
| Secondary | HBV DNA decrease level | week24, 48, 72 and 96 | HBV DNA decrease compared with baseline（log10 copies/ml） |
| Secondary | HBV DNA negativity rate | week 24, 48 and 72 | HBV DNA \< 500 copies/ml |
| Secondary | biochemical response | week 24,48,72 and 96 | ALT normalization |
| Secondary | HBeAg loss | week 24,48,72 and 96 | HBeAg loss in HBeAg positive group |
| Secondary | HBeAg seroconversion | week 24,48,72 and 96 | HBeAg seroconversion in HBeAg positive group |
| Secondary | HBeAg reversion | week 24,48,72 and 96 | HBeAg positive in Baseline HBeAg negativie group patients |
| Secondary | HBsAg loss | week 24,48,72 and 96 | HBsAg loss in both group |
| Secondary | HBsAg seroconversion | week 24,48,72 and 96 | HBsAg loss and anti-HBs positive |
| Secondary | adverse event | week 24,48,72 and 96 | type and rate of adverse events;type and rate of severe adverse event; |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02327663
GET https://conductscience.org/api/trials/v1/NCT02327663/registered